Large study tracks safety of common blood thinner after leg surgery
NCT ID NCT07142655
Summary
This study is collecting existing health records to monitor the safety of the approved blood thinner rivaroxaban in Japanese patients. It focuses on 1500 people with peripheral artery disease (PAD) who have had surgery to improve blood flow in their legs. Researchers are looking for any serious bleeding events or heart-related deaths to better understand the drug's safety profile in real-world use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE (PAD) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Medical Data Vision Co., Ltd
Tokyo, 101-0053, Japan
Conditions
Explore the condition pages connected to this study.